Categories AlphaGraphs, Consumer, Earnings
Earnings Preview: What to expect when Conagra reports Q4 2019 results
Conagra Brands Inc. (NYSE: CAG) is scheduled to report fourth quarter 2019 earnings results on Thursday, June 27, before market open. Wall Street anticipates the company will deliver earnings of $0.41 per share on revenue of $2.6 billion. Over the trailing four quarters, the company has topped earnings estimates three times.
Conagra has been shuffling and building its portfolio through a variety of strategic acquisitions and divestitures. These measures will prove beneficial to the company’s performance. However, the effect of divestitures might put pressure on the company’s quarterly results.
Last month, Conagra completed the sale of its Italian frozen pasta business, Gelit, to an Italian investment company owned by Consilum SGR SpA, Progressio SGR SpA, and MMM Srl for undisclosed terms. Updates on this deal and the company’s future plans will be something to watch.
The company’s bottomline is likely to be impacted by higher costs. Investments being made in its frozen and snacking business units are also likely to add to the expenses which could take a toll on earnings.
In the third quarter, Conagra topped earnings estimates despite a 16% decrease in adjusted EPS to $0.51. Net sales grew 35% to $2.7 billion but missed forecasts. The Grocery & Snacks and Refrigerated & Frozen segments continued their growth trend while Foodservice and International continued to see weakness.
For fiscal 2019, Conagra has guided for organic net sales to grow about 1%. Total company adjusted earnings from continuing operations are anticipated to be in the range of $2.03 to $2.08 per share.
Conagra’s shares have gained over 34% so far this year. The stock was down 1% in midday trade on Monday.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Comments
Comments are closed.